For medications like liraglutide, this ensures that the clinical effects, including weight reduction and gastrointestinal side effects, should be essentially identical, says Michael Genovese, MD, chief medical adviser at AscendantNY in New York City
Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial
Research context and laboratory endpoints 1
Read the full report to learn what this exciting advance could mean for your business: To view or add a comment, sign in RGA study reveals: By 2045, GLP-1s could reduce mortality by 3.5% in the US, 2.6% in Canada, 2% in the UK, and 1.4% in Hong Kong